Analysis Manzo Pharmaceuticals, Inc. (MNZO)
5/31/2024
Analysis of Manzo Pharmaceuticals, Inc. (MNZO)
Manzo Pharmaceuticals, Inc. seems to be a company with a very low stock price, currently trading at 0.00001. Looking at the technical indicators, the Relative Strength Index (RSI), Moving Average Convergence Divergence (MACD), and Moving Averages (SMA, EMA, WMA) are all indicating very low values or no significant movement.Given the limited information available, it is difficult to provide a comprehensive analysis. However, based on the data provided, it appears that Manzo Pharmaceuticals, Inc. may not be experiencing much trading activity or significant price movements at the moment. Investors should conduct further research and analysis before making any investment decisions related to this stock.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase and issuance, as well as long-term debt issuance and payments.
6. Investing activities include significant amounts related to the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational performance and strategic investments.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share both quarterly and annually, with an increase projected for the upcoming periods compared to the previous year. It indicates potential growth and improvement in the company's financial performance according to analysts' forecasts.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions about the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest that the company has experienced significant growth in the past but is expected to see a more moderate growth rate in the coming years. The next year is expected to show higher growth compared to the current year, and the next 5 years are projected to have a lower growth rate compared to the past 5 years.
Price target
The analysts' forecast for the future price of the security paper is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security paper, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating a potential opportunity for growth according to the analysts' predictions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The results for the quarter ending on January 31, 2025, were released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong cash flow with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet shows a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31%, with a fiscal year ending on September 30, 2023. The company has an EBITDA of $131.39 billion, revenue of $381.62 billion, and a diluted EPS of 6.43. The operating margin is 30.74%, with a return on assets of 22.07% and return on equity of 147.25%.
In terms of stock statistics, the company has a short ratio of 1.53, with 15.31 billion float shares and 99.29 million shares shorted. The average 10-day volume is 46.86 million shares, while the average 90-day volume is 57.50 million shares. The company has 15.33 billion shares outstanding, with 5.22% held by insiders and 57.59% held by institutions.
Valuation metrics show a PEG ratio of 26.32, forward PE of 26.32, and trailing PE of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34, price to sales ratio of 7.65, enterprise to EBITDA ratio of 22.76, and enterprise to revenue ratio of 7.73. The market capitalization is $2.92 trillion.
The stock price summary includes a beta of 1.26, 50-day moving average of $176.26, 200-day moving average of $181.04, a 52-week low of $164.08, a 52-week high of $199.62, and a 52-week change of 6.85%.
Lastly, in terms of dividends and splits, the company has a payout ratio of 14.93%, with a dividend date on May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split factor. The forward annual dividend rate is $1, with a 5-year average dividend yield of 0.73% and a forward annual dividend yield of 0.53%. The trailing annual dividend rate is $0.97, with a trailing annual dividend yield of 0.51%.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: $383,285,000,000
2. Fiscal Year 2022: $394,328,000,000
3. Fiscal Year 2021: $365,817,000,000
4. Fiscal Year 2020: $274,515,000,000
From these numbers, we can observe the following trends:
- The company experienced a steady increase in revenue from 2020 to 2022, with a slight decrease in 2023.
- There was a significant jump in revenue from 2020 to 2021, followed by a slight decrease in 2022 and a further decrease in 2023.
- Overall, the company has shown growth in revenue over the past four years, despite fluctuations in certain years.
These revenue figures provide insights into the company's performance and can be used to analyze its financial health and growth trajectory.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, peaking at $234,386,000,000 in 2018.
4. Total liabilities have also been on the rise, with the highest value in 2018 at $255,355,000,000.
5. Shareholders' equity has generally increased, with the highest value in 2018 at $107,147,000,000.
6. The company has been investing more in non-current assets and retaining earnings over the years.
MACD of MNZO
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
